Elicio Therapeutics Inc (ELTX) Directors and Executive Officers

Officers & Directors

Yekaterina (Katie) Chudnovsky - Director

Robert R. Ruffolo, Jr., Ph.D. - Director

Jay Venkatesan, M.D. - Director

Carol Ashe - Director

Karen Wilson - Director

Allen Nissenson, M.D. - Director

Julian Adams, Ph.D. - Director

Robert Connelly - Chief Executive Officer, President and Director

Brian Piekos - Chief Financial Officer

Baker Tilly US, LLP - Auditor,

Elicio Therapeutics Inc currently has 33 employees.

News about Elicio Therapeutics Inc Key Personnel

Elicio Therapeutics Announces Proposed Public Offering to Expand Pipeline of Novel Immunotherapies for Cancer Treatment

BOSTON, June 27, 2024 - Elicio Therapeutics, Inc. (Nasdaq: ELTX) has taken a significant step towards advancing its clinical-stage biotechnology portfolio with the announcement of a proposed public offering. As a pioneer in the development of innovative immunotherapies for cancer treatment, Elicio aims to leverage this offering to further accelerate the advancement of its pipeline.
The underwritten public offering includes shares of Elicio s common stock along with accompanying common warrants. Additionally, certain investors will have the option to acquire pre-funded warrants for the purchase of common stock and accompanying common warrants. All of the common stock, pre-funded warrants, and accompa...